甲状旁腺激素通过SIK2/ChREBP调控白色脂肪组织棕色化的机制研究
批准号:
82100827
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
何泱
依托单位:
学科分类:
甲状腺、甲状旁腺及相关疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
何泱
中文摘要
原发性甲状旁腺功能亢进症(PHPT)是以甲状旁腺激素(PTH)自主过度分泌为中心的内分泌系统第三大常见疾病,探索PTH的病理生理作用成为理解该疾病的核心。申请人在临床工作中观察到PHPT患者BMI随PTH升高而显著降低的现像,引发了对于PTH是否会作用于脂肪并调控能量代谢的思考。申请人在前期工作中构建模拟PHPT的小鼠模型,该小鼠体重体脂下降、代谢率增高、白色脂肪棕色化,提示PTH可能通过促进脂肪棕色化而降低体重;全转录组测序发现ChREBP可能是该小鼠脂肪棕色化的重要中介分子,而近年发现SIK2是ChREBP的重要调控因子,且SIK2活性受到PTH受体下游通路的调控,因而本研究从多层面探讨PTH通过SIK2/ChREBP通路促进白色脂肪组织棕色化并调控能量代谢的机制。本研究拓展了PTH作为经典的钙磷代谢激素的内涵,丰富了临床医生对PHPT疾病的认识,为寻找肥胖症的治疗靶点提供新视角。
英文摘要
Primary hyperparathyroidism (PHPT) is the third most common endocrine disease characterized by the uncontrolled secretion of parathyroid hormone(PTH). Exploring the pathophysiological effect of PTH turns to be the key point in understanding PHPT. Interestingly, we recently observed in our clinical practice that PTH was negatively associated with BMI, promoting us to ask whether PTH could act on adipose tissue and regulate the energy metabolim. In our preliminary work, a mouse model mimicking PHPT was built and it showed reduced body weight, reduced body fat content with increased metabolic rate and white adipose tissue browning, indicating that PTH negatively regulates energy balance through promoting adipose tissue browning . The result from PHPT RNA seq indicates that ChREBP might be a key factor in the browning process of PHPT. Recently, it was reported that SIK2 is one of important factors in regulating ChREBP. Meanwhile, the activity of SIK2 is controlled by the PTH receptor and its downstream signaling. Thus, this study was aimed to show that PTH promotes white adipose tissue browning and energy metabolism through SIK2/ChREBP pathway. This work provides a new insight into the effect of the classical calcium regulating parathyroid hormone, provides new knowledge of the PHPT, and will be promising in fighting against the obesity.
原发性甲状旁腺功能亢进症(PHPT)是以甲状旁腺激素(PTH)自主过度分泌为中心的内分泌系统第三大常见疾病,探索PTH的病理生理作用成为理解该疾病的核心,本研究通过人群、小鼠、细胞三个层面,揭示了PTH通过促进白色脂肪组织棕色化从而调控能量代谢,而SIK2/ChREBP通路则是PTH发挥上述作用的潜在机制之一。本研究中,在人群层面,我们分析了496例PHPT患者的临床数据,发现BMI随PTH升高而显著降低,随后我们回顾性分析了20例PHPT患者的PET/CT影像,结果发PHPT患者米色/棕色脂肪代谢活性显著高于对照组患者;在小鼠层面,我们通过尾静脉注射过表达PTH基因的腺相关病毒构建了模拟PHPT病理生理状态的高PTH血症小鼠模型,结果发现该小鼠体重减轻、体脂率下降、葡萄糖耐量改善,代谢笼试验提示该小鼠体重的下降来自于能量消耗增加,后续的形态学及分子生物学学试验发现高PTH血症小鼠白色脂肪的形态及分子表型向棕色脂肪转变;此外,小鼠皮下注射PTH后,其白色脂肪组织中UCP1等产热相关基因表达显著增加;在细胞层面,PTH体外干预小鼠原代前体脂肪细胞促进了其向棕色脂肪细胞方向分化;上述结果提示PTH通过促进白色脂肪组织棕色化进而增加能量消耗、降低体脂率及体重。随后我们进行了机制探讨,高PTH血症小鼠脂肪组织全转录组测序发现ChREBP可能是该小鼠脂肪棕色化的重要中介分子;高PTH血症小鼠ChREBP基因表达显著增加,且其上游的负向调控因子SIK2发生了显著磷酸化而失活;而敲低前体脂肪细胞ChREBP基因则显著减低了PTH对于原代脂肪细胞向棕色脂肪细胞分化的促进作用,因此SIK2/ChREBP通路是PTH促进白色脂肪棕色化的潜在机制之一。本研究拓展了PTH作为经典的钙磷代谢激素的内涵,丰富了临床医生对PHPT疾病的认识,为寻找肥胖症的治疗靶点提供新视角。
国内基金
海外基金